Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.623
+0.228 (57.77%)
At close: Feb 27, 2026, 4:00 PM EST
0.580
-0.043 (-6.93%)
After-hours: Feb 27, 2026, 7:59 PM EST
Ensysce Biosciences Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Ensysce Biosciences.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Ensysce Biosciences.
Recommendation Trends
| Rating | May '23 | Jun '23 | Jul '23 | Aug '23 | Sep '23 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 2 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $135 → $105 | Strong Buy | Maintains | $135 → $105 | +16,748.52% | Sep 25, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $135 | Strong Buy | Initiates | $135 | +21,562.39% | Jul 3, 2023 |
| Lake Street | Lake Street | Strong Buy Maintains $14,400 → $1,440 | Strong Buy | Maintains | $14,400 → $1,440 | +230,965.47% | Nov 17, 2022 |
| Lake Street | Lake Street | Strong Buy Initiates $14,400 | Strong Buy | Initiates | $14,400 | +2,310,554.69% | Nov 30, 2021 |
Financial Forecast
Revenue This Year
3.77M
from 5.21M
Decreased by -27.56%
Revenue Next Year
n/a
from 3.77M
EPS This Year
-4.82
from -11.45
EPS Next Year
-0.30
from -4.82
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 3.9M | n/a | |
| Avg | 3.8M | n/a | |
| Low | 3.6M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -25.4% | - | |
| Avg | -27.6% | - | |
| Low | -30.4% | - |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -4.97 | -0.30 |
| Avg | -4.82 | -0.30 |
| Low | -4.64 | -0.28 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.